Literature DB >> 21755604

The pharmacology and toxicology of the synthetic cathinone mephedrone (4-methylmethcathinone).

Paul I Dargan1, Roumen Sedefov, Ana Gallegos, David M Wood.   

Abstract

Mephedrone (4-methylmethcathinone) is a synthetic cathinone that is used as a recreational drug. It has been available since 2007 but its availability and use increased significantly during 2009 and 2010. In this review article we will summarize the available literature on the sources, availability, and prevalence of the use of mephedrone. We will also discuss the pharmacology of mephedrone, the patterns of acute toxicity associated with its use, the reports of fatalities associated with its use, and the potential for mephedrone dependence.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21755604     DOI: 10.1002/dta.312

Source DB:  PubMed          Journal:  Drug Test Anal        ISSN: 1942-7603            Impact factor:   3.345


  24 in total

Review 1.  The preclinical pharmacology of mephedrone; not just MDMA by another name.

Authors:  A R Green; M V King; S E Shortall; K C F Fone
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

Review 2.  Synthetic cathinones ("bath salts").

Authors:  Matthew L Banks; Travis J Worst; Daniel E Rusyniak; Jon E Sprague
Journal:  J Emerg Med       Date:  2014-02-22       Impact factor: 1.484

3.  Five things to know about..."bath salts".

Authors:  Tony Antoniou; David N Juurlink
Journal:  CMAJ       Date:  2012-08-20       Impact factor: 8.262

4.  Awash in a sea of 'bath salts': implications for biomedical research and public health.

Authors:  Michael H Baumann
Journal:  Addiction       Date:  2014-07-01       Impact factor: 6.526

5.  Clinical and toxicological findings of acute intoxication with synthetic cannabinoids and cathinones.

Authors:  Yuji Fujita; Atsuhiko Koeda; Yasuhisa Fujino; Makoto Onodera; Satoshi Kikuchi; Hisae Niitsu; Yasumasa Iwasaki; Kiyotaka Usui; Yoshihiro Inoue
Journal:  Acute Med Surg       Date:  2015-12-28

6.  Risk of caffeine toxicity associated with the use of 'legal highs' (novel psychoactive substances).

Authors:  Susannah Davies; Terry Lee; John Ramsey; Paul I Dargan; David M Wood
Journal:  Eur J Clin Pharmacol       Date:  2011-10-29       Impact factor: 2.953

7.  A case series of individuals with analytically confirmed acute diphenyl-2-pyrrolidinemethanol (D2PM) toxicity.

Authors:  David M Wood; Malgorzata Puchnarewicz; Atholl Johnston; Paul I Dargan
Journal:  Eur J Clin Pharmacol       Date:  2011-10-29       Impact factor: 2.953

8.  Acute kidney injury requiring haemodialysis following ingestion of mephedrone.

Authors:  Rhys Rhidian; Adarsh Babu
Journal:  BMJ Case Rep       Date:  2013-03-01

9.  Healthcare professionals are less confident in managing acute toxicity related to the use of new psychoactive substances (NPS) compared with classical recreational drugs.

Authors:  D M Wood; B Ceronie; P I Dargan
Journal:  QJM       Date:  2015-11-15

10.  Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.

Authors:  S E Shortall; A R Green; K M Swift; K C F Fone; M V King
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.